These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 7954464

  • 1. Improved tumor targeting with chemically cross-linked recombinant antibody fragments.
    King DJ, Turner A, Farnsworth AP, Adair JR, Owens RJ, Pedley RB, Baldock D, Proudfoot KA, Lawson AD, Beeley NR.
    Cancer Res; 1994 Dec 01; 54(23):6176-85. PubMed ID: 7954464
    [Abstract] [Full Text] [Related]

  • 2. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 3. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL, Pedley RB, King DJ, Green AJ, Yarranton GT, Begent RH.
    Br J Cancer; 1999 Nov 01; 81(6):972-80. PubMed ID: 10576653
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A, Batra SK.
    Q J Nucl Med; 1998 Dec 01; 42(4):225-41. PubMed ID: 9973838
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
    Casey JL, King DJ, Chaplin LC, Haines AM, Pedley RB, Mountain A, Yarranton GT, Begent RH.
    Br J Cancer; 1996 Nov 01; 74(9):1397-405. PubMed ID: 8912535
    [Abstract] [Full Text] [Related]

  • 7. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
    Kang N, Hamilton S, Odili J, Wilson G, Kupsch J.
    Clin Cancer Res; 2000 Dec 01; 6(12):4921-31. PubMed ID: 11156253
    [Abstract] [Full Text] [Related]

  • 8. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
    Sharkey RM, Motta-Hennessy C, Pawlyk D, Siegel JA, Goldenberg DM.
    Cancer Res; 1990 Apr 15; 50(8):2330-6. PubMed ID: 2180566
    [Abstract] [Full Text] [Related]

  • 9. Assessment of radiolabeled stabilized F(ab')2 fragments of monoclonal antiferritin in nude mouse model.
    Quadri SM, Lai J, Mohammadpour H, Vriesendorp HM, Williams JR.
    J Nucl Med; 1993 Dec 15; 34(12):2152-9. PubMed ID: 8254403
    [Abstract] [Full Text] [Related]

  • 10. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
    Behr TM, Sgouros G, Stabin MG, Béhé M, Angerstein C, Blumenthal RD, Apostolidis C, Molinet R, Sharkey RM, Koch L, Goldenberg DM, Becker W.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
    [Abstract] [Full Text] [Related]

  • 11. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J.
    Cancer Res; 1993 Aug 15; 53(16):3776-83. PubMed ID: 8339291
    [Abstract] [Full Text] [Related]

  • 12. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM, Karacay H, Richel H, McBride WJ, Rossi EA, Chang K, Yeldell D, Griffiths GL, Hansen HJ, Goldenberg DM.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [Abstract] [Full Text] [Related]

  • 13. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
    Glennie MJ, McBride HM, Worth AT, Stevenson GT.
    J Immunol; 1987 Oct 01; 139(7):2367-75. PubMed ID: 2958547
    [Abstract] [Full Text] [Related]

  • 14. [High level expression of chimeric antibody fragment F(ab')2 directed against CD20 in Escherichia coli].
    Xiong DS, Zheng MJ, Liu YX, Xu YF, Wang JH, Yang CZ.
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep 01; 20(5):673-8. PubMed ID: 15973988
    [Abstract] [Full Text] [Related]

  • 15. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW, Allen TM.
    J Control Release; 2008 Feb 18; 126(1):50-8. PubMed ID: 18068849
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC, Chu DZ, Yamauchi DM, Williams LE, Liu A, Wilczynski S, Wu AM, Shively JE, Doroshow JH, Raubitschek AA.
    Clin Cancer Res; 2000 Oct 18; 6(10):3855-63. PubMed ID: 11051230
    [Abstract] [Full Text] [Related]

  • 18. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.
    Yokota T, Milenic DE, Whitlow M, Schlom J.
    Cancer Res; 1992 Jun 15; 52(12):3402-8. PubMed ID: 1596900
    [Abstract] [Full Text] [Related]

  • 19. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H, Yoo TM, Drumm D, Kim MK, Sun BF, Le N, Webber KO, Pastan I, Waldmann TA, Paik CH, Carrasquillo JA.
    Cancer Res; 1997 May 15; 57(10):1955-61. PubMed ID: 9157991
    [Abstract] [Full Text] [Related]

  • 20. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.
    Behr TM, Sharkey RM, Juweid ME, Blumenthal RD, Dunn RM, Griffiths GL, Bair HJ, Wolf FG, Becker WS, Goldenberg DM.
    Cancer Res; 1995 Sep 01; 55(17):3825-34. PubMed ID: 7641200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.